Form D · Pharmaceuticals
TRACT PHARMACEUTICALS, INC.
West Hartford, CT · CIK 0001842419
Offering snapshot reported Feb 2, 2021 · SEC filing
- Reported sold
- $1.16M Offering amount: $2M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 15, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 2, 2021 | Initial | $1,155,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-388157
Source: Form D, filed Feb 2, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert A. Izard | Director, Executive |
| Matthew Vincent | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
29 South Main Street Suite 305
West Hartford, CT, 06107
West Hartford, CT, 06107